TY - JOUR
T1 - Diffuse lamellar keratitis associated with carboxymethylcellulose sodium 1% after laser in situ keratomileusis
AU - Samuel, Michael A.
AU - Kaufman, Stephen C.
AU - Ahee, Jason A.
AU - Wee, Curtis
AU - Bogorad, David
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2002
Y1 - 2002
N2 - Purpose: To investigate the association between the use of carboxymethylcellulose sodium 1% (Celluvisc®) (Allergan, Inc.) during laser in situ keratomileusis (LASIK) and the development of diffuse lamellar keratitis (DLK). Setting: Outpatient surgery center, Detroit, Michigan, USA. Methods: In this retrospective case series, the postoperative clinical course and surgical outcomes in 30 eyes of 15 consecutive patients who had LASIK with the use of Celluvisc were reviewed. All patients had primary LASIK, and the incidence and severity of DLK were analyzed. Results: Diffuse lamellar keratitis developed in 24 of the 30 eyes (80.0%) in which Celluvisc was used before the keratectomy (P = < .0001, Fischer exact test). Sixteen eyes (66.7%) had stage 1, and 8 (33.3%) had stage 2. Diffuse lamellar keratitis was diagnosed in most cases (91.6%) on postoperative day 1. All inflammation resolved after treatment with intense topical corticosteroids. Conclusions: Celluvisc used immediately before the keratectomy in LASIK was highly associated with the development of DLK.
AB - Purpose: To investigate the association between the use of carboxymethylcellulose sodium 1% (Celluvisc®) (Allergan, Inc.) during laser in situ keratomileusis (LASIK) and the development of diffuse lamellar keratitis (DLK). Setting: Outpatient surgery center, Detroit, Michigan, USA. Methods: In this retrospective case series, the postoperative clinical course and surgical outcomes in 30 eyes of 15 consecutive patients who had LASIK with the use of Celluvisc were reviewed. All patients had primary LASIK, and the incidence and severity of DLK were analyzed. Results: Diffuse lamellar keratitis developed in 24 of the 30 eyes (80.0%) in which Celluvisc was used before the keratectomy (P = < .0001, Fischer exact test). Sixteen eyes (66.7%) had stage 1, and 8 (33.3%) had stage 2. Diffuse lamellar keratitis was diagnosed in most cases (91.6%) on postoperative day 1. All inflammation resolved after treatment with intense topical corticosteroids. Conclusions: Celluvisc used immediately before the keratectomy in LASIK was highly associated with the development of DLK.
UR - http://www.scopus.com/inward/record.url?scp=0036688154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036688154&partnerID=8YFLogxK
U2 - 10.1016/S0886-3350(02)01266-X
DO - 10.1016/S0886-3350(02)01266-X
M3 - Article
C2 - 12160811
AN - SCOPUS:0036688154
SN - 0886-3350
VL - 28
SP - 1409
EP - 1411
JO - Journal of cataract and refractive surgery
JF - Journal of cataract and refractive surgery
IS - 8
ER -